Clinical Studies

EMRO is continuously striving to improve on the methods patients are treated. There are a number of areas in which we research and recruit, including:

 

Actively Enrolling Clinical Studies

Study

Enrollment Criteria

Hours/Contact

ESETT #18470
The Established Status Epilepticus Treatment Trial
· Age: ≥ 18
· Witnessed to seize for >5 minute duration prior to treatment with study drug
· Continued or recurring seizure in the Emergency Department
Enrollment 24/7
PI: J. Stephen Huff, MD
LEAP!2 #19126
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults with Pneumonia
· Age: ≥18
· Symptomatic CABP
· PORT Score 50-130
· No hospitalization within 90 days
· Single dose of short-acting antibiotics allowed
Enrollment: M-F 7-7
CRC PIC 1044
PI: Sara Sutherland, MD
ETTAU-03 #19522
Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
· Age: ≥18
· Injectable treatment
· Symptoms of urticaria
Enrollment: M-F 7-7
CRC PIC 1044
PI: Thomas Hartka, MD
VIOLET #19850
Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET)
· Age: ≥18
· Enteric Vitamin D vs Placebo
· Intent to admit to ICU
· ARDS risk: PNA, aspiration, smoke inhalation, lung contusion, sepsis, pancreatitis, acute resp failure
Enrollment: M-F 7-7
CRC PIC 1044
PI: Enfield/Sochor
StandUP #19674
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure (STANDUP AHF)
· Age: ≥18
· History of HF + LVEF ≤40%
· BNP≥400
· SBP 105-160
· No ACS hosp w/i 90 days
Enrollment: M-F 7-7
CRC PIC 1044
PI: Chris Ghaemmaghami, MD

Upcoming Clinical Studies 

Winter 2017-2018
Cempra Pediatric Pneumonia – Dr. Easter PI
Crash Injury Research and Engineering Network (CIREN) – Dr. Hartka PI